Martingale Asset Management’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-27,526
| Closed | -$87.3K | – | 786 |
|
|
2023
Q3 | $87.3K | Buy |
27,526
+3,300
| +14% | +$10.5K | ﹤0.01% | 770 |
|
|
2023
Q2 | $120K | Sell |
24,226
-5
| -0% | -$25 | ﹤0.01% | 785 |
|
|
2023
Q1 | $120K | Hold |
24,231
| – | – | ﹤0.01% | 802 |
|
|
2022
Q4 | $152K | Hold |
24,231
| – | – | ﹤0.01% | 807 |
|
|
2022
Q3 | $262K | Sell |
24,231
-800
| -3% | -$8.65K | 0.01% | 737 |
|
|
2022
Q2 | $286K | Sell |
25,031
-15
| -0.1% | -$171 | 0.01% | 741 |
|
|
2022
Q1 | $229K | Hold |
25,046
| – | – | ﹤0.01% | 775 |
|
|
2021
Q4 | $374K | Buy |
25,046
+2,925
| +13% | +$43.7K | ﹤0.01% | 697 |
|
|
2021
Q3 | $569K | Buy |
22,121
+5,000
| +29% | +$129K | 0.01% | 642 |
|
|
2021
Q2 | $447K | Buy |
+17,121
| New | +$447K | 0.01% | 618 |
|